Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Teriflunomide Pregnancy Outcome Exposure Registry: An OTIS Autoimmune Diseases in Pregnancy Project

NCT03198351 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03198351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03198351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Teriflunomide Pregnancy Outcome Exposure Registry: An OTIS Autoimmune Diseases in Pregnancy Project
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
April 25, 2013
Completion date
June 13, 2023
Enrollment
220 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis